UBS reiterates Cigna stock buy rating on 2026-2030 outlook
Covered in this story
What has happened since
- Cigna is up 4.9% since this was published, 7 days ago.
Price move measured from the close nearest publication to the latest quote.
Tracked from this story
UBS’s $400 target on $CI is on the record and being tracked to Oct 2027 (12-month default), scored on the close that day.
UBS’s track record →Call it yourself
No member calls on $CI yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Cigna →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.